Youssef Daali

6.5k total citations
163 papers, 4.6k citations indexed

About

Youssef Daali is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, Youssef Daali has authored 163 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pharmacology, 32 papers in Pharmacology and 32 papers in Oncology. Recurrent topics in Youssef Daali's work include Pharmacogenetics and Drug Metabolism (67 papers), Drug Transport and Resistance Mechanisms (26 papers) and Pharmacological Effects and Toxicity Studies (19 papers). Youssef Daali is often cited by papers focused on Pharmacogenetics and Drug Metabolism (67 papers), Drug Transport and Resistance Mechanisms (26 papers) and Pharmacological Effects and Toxicity Studies (19 papers). Youssef Daali collaborates with scholars based in Switzerland, United States and France. Youssef Daali's co-authors include Jules Desmeules, Pierre Dayer, Caroline Samer, Kuntheavy Ing Lorenzini, Victoria Rollason, Serge Rudaz, Marija Bosilkovska, Jean‐Luc Reny, Pierre Fontana and Alberto Chiappe and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Youssef Daali

158 papers receiving 4.5k citations

Peers

Countries citing papers authored by Youssef Daali

Since Specialization

Citations

This map shows the geographic impact of Youssef Daali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youssef Daali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youssef Daali more than expected).

Fields of papers citing papers by Youssef Daali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youssef Daali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youssef Daali. The network helps show where Youssef Daali may publish in the future.

Co-authorship network of co-authors of Youssef Daali

This figure shows the co-authorship network connecting the top 25 collaborators of Youssef Daali. A scholar is included among the top collaborators of Youssef Daali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youssef Daali. Youssef Daali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban 2025 ·British Journal of Clinical Pharmacology ·(unknown), Jean Terrier, (unknown), Pauline Gosselin, (unknown), Camille Lenoir, Victoria Rollason, Chantal Csajka, Caroline Samer, Pierre Fontana, Youssef Daali, Jean‐Luc Reny, (unknown)	0
2	Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers 2024 ·Clinical Pharmacology & Therapeutics ·(unknown), (unknown), Yvonne Gloor, Youssef Daali, Caroline Samer	4
3	Improving CYP2C19 phenotyping using stereoselective omeprazole and 5‐hydroxy‐omeprazole metabolic ratios 2024 ·Basic & Clinical Pharmacology & Toxicology ·(unknown), Emmanuel Varesio, Julien Déglon, Caroline Samer, Youssef Daali	1
4	Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs 2023 ·Pharmaceutics ·(unknown), Clément Delage, Youssef Daali, Anne‐Priscille Trouvin, Serge Perrot, Nihel Khoudour, (unknown), Laurence Labat, Bruno Étain, Frank Bellivier, Célia Lloret‐Linares, Vanessa Bloch, Emmanuel Curis, Xavier Declèves	4
5	Practice of CYP450 genotyping and phenotyping in children in a real-life setting 2023 ·Frontiers in Pharmacology ·Frédérique Rodieux, Youssef Daali, Victoria Rollason, Caroline Samer, Kuntheavy Ing Lorenzini	2
6	Evaluation of important human CYP450 isoforms and P‐glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktail 2023 ·Basic & Clinical Pharmacology & Toxicology ·(unknown), Nooshin Shirzad, Mohammad Reza Rouini, Soha Namazi, (unknown), Alireza Esteghamati, Manouchehr Nakhjavani, (unknown), Yvonne Gloor, Youssef Daali, Yalda H. Ardakani	5
7	Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotyping 2023 ·Journal of Chromatography B ·(unknown), Caroline Samer, (unknown), Emmanuel Varesio, Youssef Daali	1
8	Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT 2023 ·Transplantation and Cellular Therapy ·(unknown), (unknown), Sonia Khier, Youssef Daali, Michael Medinger, Joerg Halter, Dominik Heim, Yves Chalandon, Urs Schanz, Gayathri Nair, Nathan Cantoni, Jakob Passweg, Chakradhara Rao S. Uppugunduri, Marc Ansari	4
9	Impact of Obesity and Bariatric Surgery on Metabolic Enzymes and P-Glycoprotein Activity Using the Geneva Cocktail Approach 2023 ·Journal of Personalized Medicine ·(unknown), Mohammad Reza Rouini, Saeed Safari, (unknown), (unknown), Kheirollah Gholami, (unknown), Yvonne Gloor, Youssef Daali, Yalda H. Ardakani	2
10	Dexamethasone exposure in normal‐weight and obese hospitalized COVID‐19 patients: An observational exploratory trial 2022 ·Clinical and Translational Science ·(unknown), Pauline Gosselin, Stéphane Guerrier, Youssef Daali, Jules Desmeules, Olivier Grosgurin, Jean‐Luc Reny, Caroline Samer, Alexandra Calmy, (unknown)	8
11	Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P‐Glycoprotein Activities 2022 ·Clinical Pharmacology & Therapeutics ·Brahim Achour, Pauline Gosselin, Jean Terrier, Yvonne Gloor, Zubida M. Al‐Majdoub, Thomas M. Polasek, Youssef Daali, Amin Rostami‐Hodjegan, Jean‐Luc Reny	22
12	Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in Humans 2022 ·Genome Biology and Evolution ·Médéric Mouterde, Youssef Daali, Victoria Rollason, (unknown), Anwar Mulugeta, Khalid Al-Balushi, Giannoulis Fakis, Theodoros C. Constantinidis, Khalid Al‐Thihli, Marie Černá, Eyasu Makonnen, Sotiria Boukouvala, Said Al‐Yahyaee, Getnet Yimer, Viktor Černý, Jules Desmeules, Estella S. Poloni	1
13	Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response 2022 ·Pharmaceuticals ·Ashwin Kamath, Suresh Kumar Srinivasamurthy, Mukta N. Chowta, Sheetal D Ullal, Youssef Daali, Chakradhara Rao S. Uppugunduri	1
14	Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy 2020 ·The Annual Review of Pharmacology and Toxicology ·Adam S. Darwich, Thomas M. Polasek, Jeffrey K Aronson, Kayode Ogungbenro, Daniel F. B. Wright, Brahim Achour, Jean‐Luc Reny, Youssef Daali, Birgit Eiermann, Jack Cook, Lawrence J. Lesko, Andrew J. McLachlan, Amin Rostami‐Hodjegan	109
15	GABAergic modulation of secondary hyperalgesia: A randomized controlled 4‐way crossover trial with the α2‐subunit preferring GABA positive allosteric modulator, N‐desmethyl‐clobazam in healthy volunteers 2020 ·European Journal of Pain ·Alain Matthey, Youssef Daali, François Curtin, Antoine Poncet, Jules Desmeules, Marie Besson	4
16	Variables of interest to predict glomerular filtration rate in preterm newborns in the first days of life 2019 ·Pediatric Nephrology ·(unknown), Christophe Combescure, Hassib Chehade, Youssef Daali, Paloma Parvex	11
17	Towards Personalized Antithrombotic Treatments: Focus on P2Y12 Inhibitors and Direct Oral Anticoagulants 2019 ·Clinical Pharmacokinetics ·Jean Terrier, Youssef Daali, Pierre Fontana, Chantal Csajka, Jean‐Luc Reny	7
18	Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs 2013 ·Drug Metabolism and Disposition ·Youssef Daali, P. Millet, Pierre Dayer, Catherine M. Pastor	16
19	Codeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism 2004 ·New England Journal of Medicine ·Yvan Gasche, Youssef Daali, Marc Fathi, Alberto Chiappe, Silvia Cottini, Pierre Dayer, Jules Desmeules	450
20	Use of borate complexation for the separation of non-UV-absorbing calystegines by capillary electrophoresis 2000 ·Journal of Chromatography A ·Youssef Daali, Khalid Bekkouche, Samir Cherkaoui, Philippe Christen, Jean‐Luc Veuthey	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact